Filing Details
Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 06, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:CDIO
Cardio Diagnostics Holdings, Inc. (CDIO) Files Quarterly Report for Q0
Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 06, 2026.
At publication ·
What changed
Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Cardio Diagnostics Holdings filed its Q0 2026 quarterly report on November 6, 2026 with the SEC.
- The company's stock trades at $1.68 per share with a market capitalization of $7.1 million.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance and emerging trends.
Market Context
Cardio Diagnostics Holdings, Inc.'s stock currently trades at $1.68 with a market capitalization of $7.1M.
The 10-Q provides Cardio Diagnostics Holdings, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Cardio Diagnostics Holdings, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CDIO Stock Page
Frequently Asked Questions
Where can I read CDIO's SEC filings?
Browse all filings on our CDIO SEC filings page.
What types of SEC filings does Cardio Diagnostics Holdings, Inc. file?
Public companies like Cardio Diagnostics Holdings, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.